GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » H. Lundbeck AS (OTCPK:HLUBF) » Definitions » Inventories, Work In Process

HLUBF (H. Lundbeck AS) Inventories, Work In Process : $0 Mil (As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is H. Lundbeck AS Inventories, Work In Process?

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. H. Lundbeck AS's work in process for the quarter that ended in Sep. 2024 was $0 Mil.


H. Lundbeck AS Inventories, Work In Process Historical Data

The historical data trend for H. Lundbeck AS's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

H. Lundbeck AS Inventories, Work In Process Chart

H. Lundbeck AS Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Work In Process
Get a 7-Day Free Trial Premium Member Only Premium Member Only 161.24 188.87 233.10 314.26 377.48

H. Lundbeck AS Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Inventories, Work In Process Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 377.48 - - -

H. Lundbeck AS Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.


H. Lundbeck AS Business Description

Address
Ottiliavej 9, Valby, DNK, 2500
Lundbeck is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous system drugs including antidepressants, antipsychotics, and antiepileptic products. The company's portfolio includes Abilify Maintena and Rexulti for psychosis, Brintellix/Trintellix for depression, Northera for Parkinson's disease symptoms, Sabril and Onfi for seizures, and Vyepti for migraine prevention. Most of the company's sales are derived in North America, followed by Asia and Europe.

H. Lundbeck AS Headlines

From GuruFocus

Q3 2023 H Lundbeck A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q1 2020 H Lundbeck A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q3 2020 H Lundbeck A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q2 2022 H Lundbeck A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q1 2022 H Lundbeck A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Full Year 2022 H Lundbeck A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q1 2023 H Lundbeck A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q4 2020 H Lundbeck A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024